Citations to this article

Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist
Chris M. Storgard, … , Robert I. Fox, David A. Cheresh
Chris M. Storgard, … , Robert I. Fox, David A. Cheresh
Published January 1, 1999
Citation Information: J Clin Invest. 1999;103(1):47-54. https://doi.org/10.1172/JCI3756.
View: Text | PDF
Article Article has an altmetric score of 6

Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist

Abstract

Rheumatoid arthritis (RA) is an inflammatory disease associated with intense angiogenesis and vascular expression of integrin αvβ3. Intra-articular administration of a cyclic peptide antagonist of integrin αvβ3 to rabbits with antigen-induced arthritis early in disease resulted in inhibition of synovial angiogenesis and reduced synovial cell infiltrate, pannus formation, and cartilage erosions. These effects were not associated with lymphopenia or impairment of leukocyte function. Furthermore, when administered in chronic, preexisting disease, the αvβ3 antagonist effectively diminished arthritis severity and was associated with a quantitative increase in apoptosis of the angiogenic blood vessels. Therefore, angiogenesis appears to be a central factor in the initiation and persistence of arthritic disease, and antagonists of integrin αvβ3 may represent a novel therapeutic strategy for RA.

Authors

Chris M. Storgard, Dwayne G. Stupack, Alfred Jonczyk, Simon L. Goodman, Robert I. Fox, David A. Cheresh

×

Total citations by year

Year: 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1995 1991 Total
Citations: 3 3 3 3 6 3 3 2 2 5 9 6 117 6 9 17 11 18 15 13 18 21 22 23 12 1 1 1 353
Citation information

Citations to this article in year 2001 (22)

Title and authors Publication Year
IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis
IB McInnes, GG Illei, CL Danning, CH Yarboro, M Crane, T Kuroiwa, R Schlimgen, E Lee, B Foster, D Flemming, C Prussin, TA Fleisher, DT Boumpas 		Journal of immunology (Baltimore, Md. : 1950) 2001
Evidence of IL-18 as a novel angiogenic mediator
CC Park, JC Morel, MA Amin, MA Connors, LA Harlow, AE Koch 		Journal of immunology (Baltimore, Md. : 1950) 2001
Antagonism of the Osteoclast Vitronectin Receptor with an Orally Active Nonpeptide Inhibitor Prevents Cancellous Bone Loss in the Ovariectomized Rat
MW Lark, GB Stroup, RA Dodds, R Kapadia, SJ Hoffman, SM Hwang, IE James, B Lechowska, X Liang, DJ Rieman, KL Salyers, K Ward, BR Smith, WH Miller, WF Huffman, M Gowen 		Journal of Bone and Mineral Research 2001
Angiogenesis in the pathogenesis of inflammatory joint and lung diseases
DA Walsh, CI Pearson 		Arthritis research 2001
Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins
DG Stupack, XS Puente, S Boutsaboualoy, CM Storgard, DA Cheresh 		The Journal of Cell Biology 2001
Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature
DM Gerlag, E Borges, PP Tak, HM Ellerby, DE Bredesen, R Pasqualini, E Ruoslahti, GS Firestein 		Arthritis research 2001
Antagonising angiogenesis in rheumatoid arthritis
PE Brenchley 		Annals of the rheumatic diseases 2001
POTENTIAL BIOLOGIC AGENTS FOR TREATING RHEUMATOID ARTHRITIS
LW Moreland 		Rheumatic Disease Clinics of North America 2001
Tumour angiogenesis: a novel therapeutic target in patients with malignant disease
KJ O’Byrne, WP Steward 		Expert Opinion on Emerging Drugs 2001
RHEUMATOID ARTHRITIS
IB McInnes 		Rheumatic Disease Clinics of North America 2001
Emerging therapies in osteoporosis
BR MacDonald, M Gowen 		Best Practice & Research Clinical Rheumatology 2001
Expression of ID Family Genes in the Synovia from Patients with Rheumatoid Arthritis
D Sakurai, A Yamaguchi, N Tsuchiya, K Yamamoto, K Tokunaga 		Biochemical and Biophysical Research Communications 2001
Expression of angiogenic factors in juvenile rheumatoid arthritis: Correlation with revascularization of human synovium engrafted into SCID mice
MP Scola, T Imagawa, GP Boivin, EH Giannini, DN Glass, R Hirsch, AA Grom 		Arthritis & Rheumatism 2001
Power doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: A comparison with dynamic magnetic resonance imaging
M Szkudlarek, M Court-Payen, C Strandberg, M Klarlund, T Klausen, M �stergaard 		Arthritis & Rheumatism 2001
Epithelium-fibroblast interactions in response to airway inflammation
D Knight 		Immunology and Cell Biology 2001
Vascular smooth muscle cell growth-promoting factor/F-spondin inhibits angiogenesis via the blockade of integrin ?v?3 on vascular endothelial cells
Y Terai, M Abe, K Miyamoto, M Koike, M Yamasaki, M Ueda, M Ueki, Y Sato 		Journal of Cellular Physiology 2001
Angiogenesis: regulators and clinical applications
S Liekens, ED Clercq, J Neyts 		Biochemical Pharmacology 2001
Membrane Type 1-Matrix Metalloproteinase Is Activated during Migration of Human Endothelial Cells and Modulates Endothelial Motility and Matrix Remodeling
BG Gálvez, S Matı́as-Román, JP Albar, F Sánchez-Madrid, AG Arroyo 		The Journal of biological chemistry 2001
Association of clinical, radiological and synovial immunopathological responses to anti‐rheumatic treatment in rheumatoid arthritis
AR Pettit, H Weedon, M Ahern, S Zehntner, IH Frazer, J Slavotinek, V Au, MD Smith, R Thomas 		Rheumatology (Oxford, England) 2001
Integrin and Growth Factor Receptor Crosstalk
BP Eliceiri 		Circulation research 2001
Selective α v β 3 -Receptor Blockade Reduces Macrophage Infiltration and Restenosis After Balloon Angioplasty in the Atherosclerotic Rabbit
GG Bishop, JA McPherson, JM Sanders, SE Hesselbacher, MJ Feldman, CA McNamara, LW Gimple, ER Powers, SA Mousa, IJ Sarembock 		Circulation 2001
Integrins in Vascular Development
PA Rupp, CD Little 		Circulation research 2001

Advertisement